CLRB News and Press, Cellectar Biosciences Inc. From 05/20/21

FLORHAM PARK, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a poster presentation at the American Society ...

FLORHAM PARK, N.J., May 14, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the company will participate and be available ...

Cellectar Biosciences (CLRB): Q1 GAAP EPS of -$0.13 beats by $0.03.Cash and cash equivalents of $53.63M.Press Release For further details see: Cellectar Biosciences EPS beats by $0.03

Initiated pivotal study of CLR 131 in Waldenstrom’s macroglobulinemia (WM) Received European Orphan Drug Designation for CLR 131 in WM Strong cash position of approximately $54 million providing cash runway into Q3 2023 FLORHAM PARK, N.J., May 10, 2021 (GLOBE NE...

Cellectar Biosciences (CLRB) announces that it has received notification of formal grant of the patent titled, "Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles" by the Eurasian, Australian and Mexican patent authorities.The patent provides composition of matter and use prote...

FLORHAM PARK, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it has received noti...

Innovation, R&D and an aging population are long-term secular trends that will provide a tailwind to the biotechnology sector. The Insurgent AI Deep Innovation Model uses Deep Learning and secular tailwinds to generate alpha. Evaluating investment strategies is challenging, es...

Can-Fite BioPharma Ltd. (CANF) +87% on out-licensing psoriasis, liver disease drug rights.SunLink Health Systems, Inc. (SSY) +55% on announcing $2 Million expansion, capital and operating improvements at Trace Regional Hospital.Annovis Bio, Inc. (ANVS) +37% as ANVS401 improves ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

The following slide deck was published by Cellectar Biosciences, Inc. in conjunction with this event. For further details see: Cellectar Biosciences (CLRB) Investor Presentation - Slideshow